Who has invested in VivaVision Biotech?

V Capital, Shengze Investment, Sunbow Capital, VVB Fund are named among the investors backing VivaVision Biotech.

VivaVision Biotech Funding: $103M Raised, Series D

VivaVision Biotech funding overview

VivaVision Biotech is based in Wenzhou, Zhejiang, China. VivaVision Biotech has raised $103M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series D. Investors on record include V Capital, Shengze Investment, Sunbow Capital, VVB Fund. 4 distinct backers are named across the disclosed rounds.

VivaVision Biotech at a glance

Total raised: $103M
Latest round: Series D
Headquarters: Wenzhou, Zhejiang, China
Notable investors: V Capital, Shengze Investment, Sunbow Capital, VVB Fund

Frequently asked about VivaVision Biotech funding

How much has VivaVision Biotech raised?: VivaVision Biotech has raised $103M in total disclosed funding across the rounds on record.
Who has invested in VivaVision Biotech?: V Capital, Shengze Investment, Sunbow Capital, VVB Fund are named among the investors backing VivaVision Biotech.
What was the latest VivaVision Biotech funding round?: The most recent disclosed round is a Series D.
Where is VivaVision Biotech based?: VivaVision Biotech is based in Wenzhou, Zhejiang, China.

Round data for VivaVision Biotech is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in Wenzhou and backer lists below.

VivaVision Biotech Funding: $103M Raised, Series D

VivaVision Biotech funding overview

VivaVision Biotech at a glance

Frequently asked about VivaVision Biotech funding

Companies related to VivaVision Biotech (31)

Browse related funding lists (2)